Log In
BCIQ
Print this Print this
 

RX-21101

  Manage Alerts
Collapse Summary General Information
Company Rexahn Pharmaceuticals Inc.
DescriptionPolymer conjugated form of docetaxel
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/08/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today